Back to Search
JOHN PETROS, M.D.
M.D.
Urology Physician
NPI: 1932116753Individual
Specialties, Licenses & Credentials
Research & Publications (20)
mtDNA mutations increase tumorigenicity in prostate cancer.
PMID 15647368·Proc Natl Acad Sci U S A·2005
7-preclinical
Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland.
PMID 19266278·Breast Cancer Res Treat·2010
8-other
Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men.
PMID 19267350·Prostate·2009
8-other
Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
PMID 18850577·Prostate·2009
7-preclinical
SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer.
PMID 18202102·Hum Mol Genet·2008
8-other
In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles.
PMID 17704780·Nat Mater·2007
7-preclinical
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry.
PMID 17546006·Nat Protoc·2007
8-other
Integrating simulation into a surgical residency program: is voluntary participation effective?
PMID 17180282·Surg Endosc·2007
8-other
Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1.
PMID 18055552·Am J Pathol·2007
7-preclinical
Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer.
PMID 17016436·Oncogene·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1365B CLIFTON RD NE
ATLANTA, GA 30322 - Phone
- (404) 778-4898
Quick Facts
- NPI
- 1932116753
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile